As a Hungarian enterprise, Gravity Research & Development Zrt. has been present on the global market for recommendation engines since 2010, helping service providers in a wide variety of industries both in Hungary and abroad. Under the brand names Yusp and Yuspify, they offer personalisation solutions based on cloud analytics to better understand and predict customer needs in providing online services. Funding from the National Research, Development and Innovation Fund has helped the company to further develop its product range with new technologies to make it more attractive and competitive on this rapidly changing market.
How does a good funding decision multiply success? The R&D community and society in general both expect promising projects financed from the National Research, Development and Innovation Fund to deliver against the objectives. Convincing performance, advanced research achievements, products of new developments, direct and indirect social benefits by the enabling power of innovation are at the focus of the highlighted gallery of completed projects all worthy of public attention.
Precision oncology has become part of everyday cancer care. The molecular profile of a tumour can be accurately mapped and a wide range of targeted drugs are available for treatment. However, it is an enormous challenge to effectively link the two areas to ensure that therapy is truly personalised. The oncology decision-support system developed by Oncompass Medicine Hungary Kft. uses artificial intelligence to analyse genetic and clinical data, and then assigns the drugs and active substances that are expected to produce the best results in a given case.
Gravity R&D Inc develops online recommender systems. The Netflix Prize contest gave them the first reference, then they received research funding, among others the predecessor of the NRDI Fund. Their customers are 50% foreigners and 50% Hungarians, and no one can beat their algorithms on the market. They pretty much know what users want even if they visit the given website for the first time. They expect their revenues doubled in 2017.